Krupamayi Research And Innovative Sciences Private Limited
Specializes in providing specialty hospital services.
2019 | Aurangabad, Maharashtra (India) | Active
Krupamayi Research And Innovative Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Krupamayi Research And Innovative Sciences
Krupamayi Research And Innovative Sciences Private Limited (KRAISPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 September 2019 (Five years and five months 11 days old ). Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Viraj Borgaonkar and Harshal Borgaonkar serve as directors at the Company.
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85300MH2019PTC330715
- Company No.
330715
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Sep 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Healthcare
Who are the key members and board of directors at Krupamayi Research And Innovative Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viraj Borgaonkar  | Director | 18-Sep-2019 | Current |
| Harshal Borgaonkar | Director | 18-Sep-2019 | Current |
Financial Performance of Krupamayi Research And Innovative Sciences.
Krupamayi Research And Innovative Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Krupamayi Research And Innovative Sciences?
In 2020, Krupamayi Research And Innovative Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Krupamayi Health Care Private Limited
Viraj Borgaonkar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Krupamayi Research And Innovative Sciences?
Unlock and access historical data on people associated with Krupamayi Research And Innovative Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Krupamayi Research And Innovative Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Krupamayi Research And Innovative Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.